Isolated pulmonary aspergillar infection in cardiac transplant recipients: case report and review.
The optimal type and duration of antifungal therapy for localized aspergillosis in cardiac transplant recipients is unclear. We report the case of a patient who had persistent invasive pulmonary aspergillosis despite prolonged treatment with amphotericin B. A combined approach using antifungal therapy and surgery appears effective for localized pulmonary disease. Aspergillar infection in solid organ transplant recipients is reviewed.
Mayer
J M
JM
Division of Infectious Disease, University of Utah Medical Center, Salt Lake City, Utah 84132.
Nimer
L
L
Carroll
K
K
D000666:Amphotericin B / Q000627:therapeutic use; D001228:Aspergillosis / Q000209:etiology* / Q000628:therapy; D001232:Aspergillus fumigatus / Q000187:drug effects / Q000302:isolation & purification; D016027:Heart Transplantation; D006801:Humans; D016867:Immunocompromised Host; D008172:Lung Diseases, Fungal / Q000209:etiology* / Q000628:therapy; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications
D000666:Amphotericin B